Difference between revisions of "Team:AFCM-Egypt"
Ahmedashry (Talk | contribs) |
Ahmedashry (Talk | contribs) |
||
| Line 142: | Line 142: | ||
</ul> | </ul> | ||
</li> | </li> | ||
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Design.html">Design</a></li> |
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Modeling.html">MODELING</a></li> |
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Safety.html">SAFETY</a></li> |
<li class="dropdown"> | <li class="dropdown"> | ||
<a>HUMAN PRACTICE <span class="caret"></span></a> | <a>HUMAN PRACTICE <span class="caret"></span></a> | ||
<ul> | <ul> | ||
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Silver.html">Silver</a></li> |
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Gold.html">Gold</a></li> |
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Integrated.html">Integrated</a></li> |
</ul> | </ul> | ||
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Attributions.html">ATTRIBUTIONS</a></li> |
| − | <li><a href=" | + | <li><a href="https://2017.igem.org/Medal_criteria.html">MEDAL CRITERIA</a></li> |
</ul> | </ul> | ||
Revision as of 13:34, 21 October 2017
Abstract
Knock-in of Circular RNA gene in Hepatocellular Carcinoma cells via CRISPR/Cas9
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers
in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-.
"Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique
that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma.
This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials.
This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-. "Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials. This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.
AFCM-Egypt
We strive to excel
click here
